Evolus (EOLS) Profit After Tax (2017 - 2026)
Evolus (EOLS) posted Profit After Tax of -$10.8 million for Q1 2026, down 1328.21% on a QoQ basis from $879000.0 in Q4 2025, and up 42.65% year-over-year from -$7.6 million in Q1 2025.
Evolus (EOLS) Profit After Tax (2017 - 2026) Analysis & Trends
Evolus' Profit After Tax history runs 10 years deep, the most recent figure standing at -$10.8 million for Q1 2026.
- Quarterly Profit After Tax rose 42.65% year-over-year to -$10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.3 million (up 25.34% YoY) and the FY2025 annual result came in at -$50.9 million, changed 0.01% from the prior year.
- Profit After Tax was -$10.8 million for Q1 2026 at Evolus, down from $879000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $879000.0 in Q4 2025 and bottomed at -$23.5 million in Q2 2022.
- A 5-year average of -$14.6 million and a median of -$15.3 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 373.41% — and 2025, when it jumped 112.09%.
- Evolus' Profit After Tax stood at -$13.2 million in 2022, then climbed by 12.17% to -$11.6 million in 2023, then surged by 37.13% to -$7.3 million in 2024, then soared by 112.09% to $879000.0 in 2025, then sank by 1328.21% to -$10.8 million in 2026.
- Business Quant data shows EOLS's Profit After Tax at -$10.8 million in Q1 2026, $879000.0 in Q4 2025, and -$15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.80 Mn |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | -15.28 Mn |
| Jun 30, 2025 | -17.14 Mn |
| Mar 31, 2025 | -18.83 Mn |
| Dec 31, 2024 | -7.27 Mn |
| Sep 30, 2024 | -19.26 Mn |
| Jun 30, 2024 | -11.35 Mn |
| Mar 31, 2024 | -13.11 Mn |
| Dec 31, 2023 | -11.56 Mn |
| Sep 30, 2023 | -16.92 Mn |
| Jun 30, 2023 | -18.14 Mn |
| Mar 31, 2023 | -14.79 Mn |
| Dec 31, 2022 | -13.16 Mn |
| Sep 30, 2022 | -20.28 Mn |
| Jun 30, 2022 | -23.47 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -18.18 Mn |
| Sep 30, 2021 | -19.43 Mn |
| Jun 30, 2021 | -15.60 Mn |